Evidence map›Paper›PMID 40108423›Full record

ArticleNature immunology2025

Navigating the path forward for evidence-based management of long COVID.

Joseph J Breen, Robert W Eisinger, Sarah W Read, John Beigel, Tara N Palmore, H Clifford Lane, Joseph P Menetski, Stacey J Adam, Elizabeth Geerling, Emma Roy and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Joseph J Breen *National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Robert W Eisinger *National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-0006-8772
Sarah W ReadNational Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.ORCID http://orcid.org/0000-0003-3876-472X
John BeigelNational Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-4879-4941
Tara N PalmoreNational Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
H Clifford LaneNational Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Joseph P MenetskiFoundation for the National Institutes of Health, North Bethesda, MD, USA.ORCID http://orcid.org/0000-0001-5657-1994
Stacey J AdamFoundation for the National Institutes of Health, North Bethesda, MD, USA.
Elizabeth GeerlingFoundation for the National Institutes of Health, North Bethesda, MD, USA.
Emma RoyFoundation for the National Institutes of Health, North Bethesda, MD, USA.
Julie GerberdingFoundation for the National Institutes of Health, North Bethesda, MD, USA.
Jeanne M MarrazzoNational Institute of Allergy and Infectious Diseases, Bethesda, MD, USA. jeanne.marrazzo@nih.gov.ORCID http://orcid.org/0000-0002-9277-7364

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40108423

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.